Adrienne Graves, Director at Harrow Health, holds 64.00K shares in Ocular Therapeutix (Ticker: OCUL), holds 1.00K shares in Harrow Health (Ticker: HROW), holds 127.51K shares in Opus Genetics (Ticker: IRD).
Adrienne Graves latest transaction was an Uninformative Buy of ―.
What was Adrienne Graves's most profitable transaction?
Adrienne Graves’s most profitable transaction was an Informative Sell of AKRXQ stock on December 12, 2014. The return on the trade was 16.10%.
What is Adrienne Graves's role in Harrow Health?
Adrienne Graves's role in Harrow Health is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.